Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib sodium for prevention of postoperative shivering
ChiCTR-TRC-12002870Phase 4Completed
- Sponsor
- Mianyang Central Hospital
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of parecoxib and tramadol in postanesthetic shivering (PAS) (3 arms), sponsored by Mianyang Central Hospital. Primary endpoint: shivering. Started Dec 2011; status: completed.
02
Drugs
parecoxibtramadol
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on ChiCTR-TRC-12002870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002870.